Guangdong Pharmaceutical University

What Guangdong Pharmaceutical University does

Guangdong Pharmaceutical University (广东药科大学) is a public university under the Guangdong Provincial People's Government, founded in 1958 and headquartered in Guangzhou. It is one of only three independently established pharmaceutical universities in China and operates as a comprehensive institution with a "medicine-focused, medicine-healthcare integration, medicine-engineering fusion" (以药为主，药医结合，药工融合) positioning. The university serves approximately 29,000 full-time undergraduate, graduate, and international students across 19 colleges, supported by 2,978 full-time teaching staff and five campuses spanning 5,300 acres in Guangzhou, Zhongshan, and Yunfu.

The university's core products include undergraduate education (49 programs), graduate education (2 doctoral and 5 master's first-level disciplines, 9 professional master's categories), international joint-degree pathways (3+1 and 3+2 with UK and Australian partners), and continuing education distributed across 14 Guangdong cities. Core technology platforms span pharmaceutical sciences, integrated Traditional Chinese Medicine-Western Medicine, biomedical engineering, and public health, with particular strength in glycolipid metabolic disease research. The Ministry of Education Key Laboratory of Glycolipid Metabolic Disease and the Small Molecule Drug Engineering Research Center anchor 64 national/provincial research platforms, supporting proprietary innovations including Zhenzhu Tiaozhi Capsule, Naomai Tong Granules, and Chinese Pharmacopoeia standards, with 600+ patents and 338 million RMB in cumulative technology transfer revenue.

Revenue is generated through government appropriations, tuition and educational services, research grants and contracts, technology transfer and IP licensing (highlighted by a 150 million yuan 2025 deal with Guizhou Sanli Pharmaceutical), and healthcare services from two direct-affiliated Grade-A tertiary hospitals and a network of 15 additional affiliated/cooperative hospitals. Customer segments include domestic degree-seeking students, international students from 40+ countries, healthcare-industry professionals seeking continuing education, and pharmaceutical enterprises pursuing research collaboration and technology commercialization.

Name

Guangdong Pharmaceutical University

Legal name

广东药科大学

Website

https://gdpu.edu.cn

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

51–100 employees

Short description

Guangdong Pharmaceutical University is a public Chinese university (founded 1958, Guangzhou) offering undergraduate-to-doctoral pharmaceutical, TCM, and clinical medicine education to 29,000+ students across five campuses, supported by 17 affiliated hospitals and 64 research platforms.

Ownership category

akta.pro rank

Product category

Higher Education - Pharmaceutical Sciences

NAICS

Colleges, Universities, and Professional Schools (6113), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Pharmaceutical Preparations (2834), Services-Hospitals (8060), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Schools of Pharmacy (EDAHAGAE)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Pharmaceuticals & Biotechnology (EDABALAU), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Pharmaceutical education
• Medical education
• Traditional Chinese medicine research
• Clinical medical training
• Public health education

Headquarters

HQ city

Guangzhou, Guangdong Province

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Tuition and Educational Services: Revenue from undergraduate, graduate, international, and continuing education tuition fees.
2. Research Grants and Contracts: Funding from national, provincial, and ministerial research programs; technology transfer and contract research.
3. Technology Transfer and Intellectual Property: Revenue from commercialization of research findings, patents, and proprietary technologies; 2025 cooperation with Guizhou Sanli Pharma valued at 150 million yuan.
4. Healthcare Services (Affiliated Hospitals): Medical service revenue from affiliated Grade-A tertiary hospitals.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Guangdong Pharmaceutical University is a public university providing a complete pharmaceutical and medical education pipeline from undergraduate to doctoral levels across 19 colleges and schools. The university delivers degree programs in pharmacy, traditional Chinese medicine, clinical medicine, public health, and biomedical engineering, supported by 64 national and provincial research platforms. It operates two directly affiliated Grade-A tertiary hospitals and 15 affiliated/cooperative hospitals for clinical training, and conducts technology transfer of proprietary Chinese medicine innovations including Zhenzhu Tiaozhi Capsule and Naomai Tong Granules.

Product overview

Guangdong Pharmaceutical University is a comprehensive public university specializing in pharmaceutical sciences with integrated medical and engineering programs. The university offers a complete educational pipeline from undergraduate to doctoral levels across 19 colleges, providing undergraduate education, graduate education, international programs, and continuing education. The institution operates two directly affiliated Grade A hospitals and maintains 64 national and provincial research platforms. Core offerings include academic degree programs in pharmacy, traditional Chinese medicine, clinical medicine, public health, and related disciplines, supported by research institutes focused on drug development, metabolism disorders, and traditional Chinese medicine. The university also provides technology transfer services through industrial research institutes and operates academic journals for scholarly dissemination.

Differentiator

Problem solved

Functional benefit

Brands

• 广药大名师名家名医大讲坛: Distinguished lectureship series featuring renowned scholars, experts, and medical professionals
• 广药大教授论坛
• 笃行大讲坛

Products and services

• Undergraduate Education (本科教育) Full-time undergraduate degree programs across pharmacy, medicine, engineering, management, and other disciplines, with 49 undergraduate programs including 6 national-level first-class programs, offered to students entering through the national college entrance examination system.
• Graduate Education (研究生教育) Master's and doctoral programs including 2 doctoral degree granting points in pharmacy and integrated Chinese-Western medicine, 5 master's degree first-level disciplines, and 9 professional master's degree categories, supporting advanced research training.
• International Education (国际教育) Joint training programs with universities in UK and Australia including 3+1 dual-degree and 3+2 master's programs covering Pharmacy, English, and Biopharmaceutical Sciences, plus international student recruitment from 40+ countries.
• Continuing Education (继续教育) Adult education including undergraduate and associate degree programs in pharmacy, nursing, Chinese medicine, clinical medicine, rehabilitation, food science, and cosmetic science, with off-campus teaching sites across Guangdong province for working professionals.
• Affiliated Hospitals Clinical Services (附属医院) Two directly affiliated tertiary Grade A hospitals and 15 affiliated/cooperative hospitals providing clinical teaching and medical services to patients across Guangdong Province.
• Technology Transfer and Industry Research Institutes (成果转化与产业研究院) Industrial research institutes and technology transfer platforms including Huizhou Guoxiang Industrial Research Institute and Jiyuan Neurohealth Industrial Research Institute, with cumulative technology transfer revenue of 338 million yuan over five years.
• Academic Journals (学术期刊) University-run academic journals published for scholarly communication in pharmacy and medical fields.

Quantifiable outcome

• 338 million RMB in technology transfer revenue over 5 years (2021-2025)
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• 华为技术有限公司 (Huawei Technologies)coreTechnology or Integration · 1 January 2025Guangdong Pharmaceutical University signed a framework cooperation agreement with Huawei Technologies in 2025, likely covering digital campus infrastructure, smart campus development, and digital transformation initiatives.
• 惠东县广东药科大学国香产业研究院 (HD County GDPU Guoxiang Industrial Research Institute)coreStrategic or Co-development Partner · 1 January 2025An industry research institute led by Professor Huang Chao, focusing on Guohong (Cinnamomum cassia) industry development and product commercialization.
• 济源市广东药科大学神经健康产业研究院 (Jiyuan GDPU Neurohealth Industrial Research Institute)coreStrategic or Co-development Partner · 1 January 2025An industry research institute led by Professor Xiao Xue, focused on neurological health industry development and product commercialization.
• 贵州三力制药 (Guizhou Sanli Pharmaceutical)coreStrategic or Co-development Partner · 1 January 2025In 2025, the university signed a technology transfer and cooperation project with Guizhou Sanli Pharmaceutical worth 150 million yuan, representing the largest single technology transfer deal in recent years.
• 广药-连南医联体 (GDPU-Liannan Medical Alliance)coreStrategic or Co-development Partner · 1 January 2025The 'Guangzhou Pharmaceutical University-Liannan' medical alliance model established by the Affiliated First Hospital has been recognized and promoted by the State Council Medical Reform Expert Group as a best practice.
• 一品红联瑞制药 (Yipinhong Lianrui Pharmaceutical)minorStrategic or Co-development Partner · 1 January 2025The School of Pharmacy organized a themed Party Day activity at Yipinhong Lianrui's smart pharmaceutical production base, fostering industry-academia collaboration.
• 美国堪萨斯大学 (University of Kansas)minorStrategic or Co-development Partner · 1 January 2023Professor Li Benyi from the University of Kansas visited the School of Basic Sciences for graduate academic guidance in August 2023.
• UK and Australian Universities (Joint Degree Partners)coreStrategic or Co-development Partner · 1 January 2022The university maintains joint degree programs with UK and Australian universities, offering 3+1 undergraduate dual-degree and 3+2 undergraduate-to-master's pathways. Programs cover Pharmacy, English, and Biopharmaceutical Sciences.
• 粤港澳医药产业协同创新联盟 (Guangdong-Hong Kong-Macao Pharmaceutical Industry Collaborative Innovation Alliance)coreStrategic or Co-development Partner · 1 January 2018University-led alliance bringing together pharmaceutical industry stakeholders across the Guangdong-Hong Kong-Macao Greater Bay Area for collaborative innovation in pharmaceutical research, development, and commercialization.
• 中英生物资源与创新药物联合研究中心 (Sino-UK Joint Research Centre for Biological Resources and Innovative Drugs)coreTechnology or Integration · 1 January 2016Joint research center established with University of Cambridge, focusing on biological resources and innovative drug development.

Scale indicators11 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• China Pharmaceutical University (中国药科大学): China's premier independent pharmaceutical university, also one of the three independently established pharmaceutical universities in China. Direct peer in pharmacy education, pharmaceutical sciences research, and innovation pipeline — competing for talent, research funding, and industry partnerships.
• Guangzhou University of Chinese Medicine (广州中医药大学): A leading TCM university headquartered in the same city as GDPU. Strong overlap in TCM education, integrated TCM-Western medicine research, and clinical training; competes for students, faculty, and regional TCM industry partnerships in Guangdong.
• Zhejiang Chinese Medical University (浙江中医药大学): A comparable mid-tier TCM-pharmaceutical university in eastern China with overlapping academic programs in TCM, pharmacy, and clinical medicine. Comparable institutional scale and research platform structure.
• Shenyang Pharmaceutical University (沈阳药科大学): The third independently established pharmaceutical university in China, located in the northeast. Direct peer in pharmaceutical R&D, degree programs, and industry collaboration; competes with GDPU for national recognition, faculty talent, and industry partnership deals.
• Nanjing University of Chinese Medicine (南京中医药大学): A top TCM-focused university in eastern China with similar integrated TCM-Western medicine research portfolio and pharmaceutical degree programs. Comparable in scale, structure, and academic mission to GDPU.
• Chengdu University of Traditional Chinese Medicine (成都中医药大学): One of the earliest established TCM universities in China with strong provincial backing. Direct peer in TCM pharmaceutical education, clinical research, and industry partnerships; comparable institutional structure and academic offerings.
• Tianjin University of Traditional Chinese Medicine (天津中医药大学): Another leading TCM-focused university with similar integrated TCM-Western medicine research and pharmaceutical degree offerings. Comparable in academic structure and innovation pipeline focus.

Regional players

• Southern Medical University (南方医科大学): A comprehensive medical university also located in Guangzhou with overlapping clinical medicine, pharmacy, and public health programs. Competes regionally for students and research funding; broader medical focus than GDPU.
• University of Macau Faculty of Health Sciences (澳门大学健康科学学院): Located in the Greater Bay Area with overlapping biomedical and pharmaceutical research focus. Regional peer for talent and joint research within GDPU's Guangdong-Hong Kong-Macao Pharmaceutical Industry Collaborative Innovation Alliance.

Broad incumbents

• Sun Yat-sen University School of Pharmacy (中山大学药学院): A top-tier comprehensive university's pharmacy school in Guangzhou with stronger brand recognition and research funding. Competes for top students, faculty, and industry partnerships despite narrower pharmaceutical specialization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/guangdong-parmaceutical-university

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Guangdong Pharmaceutical University